ClinicalTrials.gg
Sign In

Drug

RC48 clinical trials

Also written RC48.

studies test it
8
open now
6
in phase 3
0
first study started
2018

Keep track of what changes. Save the RC48 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Disitamab Vedotin
2

Development codes

RC48
8

Studies by the year they started

8 studies that test it; most in 2023 (3)

Studies that test RC48, by start year
YearStudies
20181
20233
20242
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
8

What it is tested for

Each study’s main condition, where its own words name it.

Stomach Neoplasms
2
Carcinoma, Non-Small-Cell Lung
1
Uterine Cervical Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1

Who runs them

Industry 1 · Other 7

The First Affiliated Hospital with Nanjing Medical University (2) · RemeGen Co., Ltd. (1) · Qilu Hospital of Shandong University (1) · Xiangya Hospital of Central South University (1) · Fudan University (1) · RenJi Hospital (1) · Peking University Cancer Hospital & Institute (1)

Often tested with

Tested in the same studies.

Iparomlimab/Tuvonralimab (1) · Adebrelimab (1) · Apatinib (1) · Tegafur (1) · Gimeracil (1) · Oxonic Acid (1) · Oxaliplatin (1) · Tislelizumab (1)

Studies

Open first, then newest update. How each study uses RC48 is read from its arms, and is right about nine times in ten.

Testing it · 8

Given in every arm · 1 — RC48 is usual care beside what is tested